Paganini, C.; Talamonti, M.; Maffei, V.; Di Raimondo, C.; Bianchi, L.; Galluzzo, M.
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks. J. Clin. Med. 2024, 13, 878.
https://doi.org/10.3390/jcm13030878
AMA Style
Paganini C, Talamonti M, Maffei V, Di Raimondo C, Bianchi L, Galluzzo M.
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks. Journal of Clinical Medicine. 2024; 13(3):878.
https://doi.org/10.3390/jcm13030878
Chicago/Turabian Style
Paganini, Claudia, Marina Talamonti, Virginia Maffei, Cosimo Di Raimondo, Luca Bianchi, and Marco Galluzzo.
2024. "Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks" Journal of Clinical Medicine 13, no. 3: 878.
https://doi.org/10.3390/jcm13030878
APA Style
Paganini, C., Talamonti, M., Maffei, V., Di Raimondo, C., Bianchi, L., & Galluzzo, M.
(2024). Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks. Journal of Clinical Medicine, 13(3), 878.
https://doi.org/10.3390/jcm13030878